Market Research Blog – Page 1559 – New Product Development

Global Automated CPR Device Market Set to Reach USD 255.7 Million by 2034 at a 5.4% of CAGR

The global automated CPR device market is projected for significant growth, with an estimated valuation of USD 150.6 million in 2024 and a forecasted increase to USD 255.7 million by 2034. This growth represents a compound annual growth rate (CAGR) of 5.4% over the assessment period.

Automated CPR devices are becoming crucial in the fight against cardiovascular disease (CVD), a leading cause of death worldwide. The rise in global cardiovascular disease incidence and the increasing need for effective resuscitation tools are key factors driving the demand for automated CPR devices.

Examine an Enlightening – Report

The need for automated CPR equipment has increased dramatically as a result of technological developments and growing public awareness of the importance of precise and efficient CPR. Modern devices have intelligent algorithms that adapt to the specific characteristics of the patient’s chest, optimizing compression depth and pace to improve circulation. Furthermore, these devices often come with integrated feedback mechanisms that ensure appropriate CPR administration and support medical practitioners instantly.

The global healthcare systems are under increasing pressure due to the rising prevalence of heart attacks and sudden cardiac arrests. Automated CPR machines have become essential pieces of equipment in emergency rooms, hospitals, and ambulances because they can begin the resuscitation process quickly, providing the patient critical time.

Key Takeaways:

In the historical period, the market captured a valuation of US$ 99.02 million in 2022.

The United States is estimated to dominate the global market by capturing a huge global market share by 2033.

Based on end-user, ambulances are leading the global market by securing a maximum share during the forecast period.

Competitive Landscape:

The automated CPR market is highly consolidated owing to the presence of regional and global market players. Key market players worldwide are employing inorganic market strategies to expand their global foothold.

Inorganic strategies include strategic mergers and acquisitions and allying with regional distributors to strengthen their supply chain channels. They are also emphasizing faster product approvals, product development, and patenting. New market entrants focus on new product launches to establish their market presence.

Other Key Players in the Global Market are:

SunLife Science Inc.
ZOLL Medical Corporation
Michigan Instruments
Physio Control Inc.
Brunswick Biomedical Technologies
Zhuhai Kindway Medical Science & Technology Co. Ltd
CPR Medical Devices Inc.
Medtronic Inc.

Recent Developments in the Global Market:

Michigan Instruments launched a hand-free automatic CPR device that is lightweight, portable, and helps smooth the transition from manual CPR to automated compressions.
ZOLL Medical Corporation introduced a new automated CPR devices system, ‘Autopulse,’ which assists EMS personnel in providing high-quality chest compressions in cramped spaces and steep down stairwells.
A new automated CPR device has been launched by Cintas, which assists healthcare professionals by providing real-time CPR feedback and monitoring, enhancing the survival rate of patients.

Automated CPR Devices Market by Category:

By Power Source:

Pneumatically Driven CPR Devices
Battery-driven CPR Devices
Mechanically Actuated And Battery-driven CPR Device

By Device Type:

Piston Devices
Load Distribution Devices
3D Compression Devices

By End User:

EMS
Hospitals
Ambulances
Coronary & Intensive Care Units
Cardiac Catheterization Labs
Air Med-Evac Units
EMT Rescue Units
Others

By Region:

North America
Latin America
Europe
Asia Pacific
The Middle East and Africa

Obtain In-Depth Market Insights – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Next Generation Infusion Pump Market is Anticipated to Reach USD 8.5 Billion by 2032 at a 4.8% CAGR | Considering FMI Analysis

The healthcare industry is undergoing a radical transformation, and the Next Generation Infusion Pump Market is at the forefront of this change. According to a recent market analysis, the global infusion pump market is poised for significant growth, reaching a substantial USD 8.5 billion by 2032. This represents a steady Compound Annual Growth Rate (CAGR) of 4.8% from its current value of USD 5059.7 million in 2022.

Next Generation Infusion Pumps are a combination of intuitive user interface, simplicity, and state-of-the-art information technology. They are inclined with an advanced pumping system that measures flow to improve workflow efficiency and patient safety. Its smartphone-like user interface is designed to diminish interpretation and programming errors empowering end users to save time and reduction in pump interactions. Next Generation Infusion Pumps are largely accepted by healthcare professionals because they provide more patient safety and efficacy.

The technology used in regular infusion pumps hasn’t kept pace with advancements in the healthcare industry. According to a report published by the institute of Medicine in 2007, from the year 2005 to 2009, 710 deaths and more than 56,000 adverse events were reported to the FDA, most amongst medical technologies, adding more than $2 Bn to annual healthcare costs in the US. On the other hand, Next Generation Infusion Pumps provide enough functionality, flexibility, scalability, affordability, and ease of use needed for the changing needs of the healthcare system, indicating robust growth in the Next Generation Infusion Pump market over the forecast period.

Claim your complimentary report with captivating visuals.
https://www.futuremarketinsights.com/reports/sample/rep-gb-4131

Next Generation Infusion Pumps attribute high integration between the pump and hospital IT system, reducing errors. Moreover, diverse new technologies like implantable insulin pumps in addition to delivering targeted, consistent medication, increase patient ease as well. The leading market players are focusing on safer operability, minimized chances of product recalls, and enhanced product designs, over the forecast period.

Next Generation Infusion Pump Market: Drivers and Restraints

Insulin infusion pumps are dominating the Next Generation Infusion Pump market, however, worldwide booming prevalence of diabetes is a key driver for the Next Generation Infusion Pump market. Increased R&D initiatives on IV drug administration for malnutrition, cancers, diabetes, AIDS, neurological disorders, and gastrointestinal disorders coupled with technological innovation, are anticipated to generate lucrative growth in the Next Generation Infusion Pump market.

The regular infusion pump market has observed massive bad press in the last few years, for diverse risks and concerns over infusion errors, this restraint, however, has opened multiple opportunities for Next Generation Infusion Pump manufacturers. Furthermore, the lack of sufficient healthcare infrastructure in developing markets is anticipated to impact negatively on the Next Generation Infusion Pump market.

Next Generation Infusion Pump Market: Overview

Next Generation Infusion Pump market is emerging owing to the promising discovery of new innovative pumps. Key players in the market are focusing on new technologies such as smartphone-connected insulin pumps, wearable insulin pumps, and implantable insulin pumps, also focusing on accessing secure and immediate access to patient-specific infusion pump management information from any mobile device or computer, regardless of Electronic Medical Record integration. Such R&D improvements are making a ground-breaking infusion management platform, indicating transformation in Next next-generation Infusion Pump Market.

Next Generation Infusion Pump Market: Region-wise Outlook

Geographically, the next-generation infusion pump market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe regions are anticipated to contribute the maximum market revenue share in Next generation infusion pump market over the forecast period due to the availability of advanced healthcare infrastructure and the presence of key players in the regions which are expected to surge the demand for next-generation infusion pumps during the forecast period in the above-mentioned region. Asia Pacific region as well, is anticipated to witness crucial growth due to growing healthcare infrastructure in the region. An increasing number of mid-sized hospitals is identified to be a major driver of the APEJ market growth.

Next Generation Infusion Pump Market: Key Players

The players leading in next next-generation infusion pump market include Ivenix, Inc., Zyno Medical, B. Braun Melsungen AG, Baxter International, Inc., F. Hoffmann-la Roche Ltd., Johnson & Johnson (U.S.), Pfizer (Hospira) Inc., and Smiths Medical to name a few.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology, and applications.

Tap into Comprehensive Segmented Information – Purchase Now!
https://www.futuremarketinsights.com/checkout/4131

The report covers an exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, and Rest of Latin America)
Western Europe (Germany, Italy, France, UK, Spain, Nordic countries, Belgium, Netherlands, Luxembourg, and the Rest of Western Europe)
Eastern Europe (Poland, Russia and Rest of Eastern Europe)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Next Generation Infusion Pump Market: Segmentation

Based on Application

Oncology
Analgesia
Diabetes
Hematology
Neonatology
Gastroenterology
Autoimmune Diseases

Based on end users

Hospitals
Ambulatory Surgical Centers (ASCs)
Clinics
Others

Report Highlights:

Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

New Born Eye Imaging Systems Market is anticipated to grow at a 5.7% CAGR to reach USD 374.3 Million by 2032 | FMI Study

The global Newborn Eye Imaging Systems Market is poised for significant growth, with a projected value of USD 374.3 million by 2032. This represents a substantial increase from the current market value of USD 202.7 million in 2022, reflecting a Compound Annual Growth Rate (CAGR) of 5.7% during this period.

The eye is the most complex sensory organ of the body, the eye is like a camera of higher resolution for capturing images, it works in a very simple process as light is focused on the eye cornea which is the lens of the eye, iris controlled the intensity of light, then the light fall on the retina for image formation then the signal generated from retain is passed through the optic nerve to the brain that controls the sense of sight.

The eye imaging system is a tool used for identifying the problem for treatment. Ophthalmic is related to the eye, major the population is suffering from eye disorders. As in newborn babies, the ROP (Retinopathy of Prematurity) is the main reason for vision loss, ROP also affects the blood vessels and spreads via the retina.

New Born Eye Imaging Systems: Drivers and Restraints

Newborn eye imaging is an emerging market, as many players are coming up with innovative devices for imaging and raising funds for research on newborn eye imaging systems, for instance, in May 2017, Visunex Medical Systems, Inc., raised a fund of USD 20 Mn for the research and development and manufacturing of newborn eye imaging system. Players are actively participating in the development of imaging systems.

Click here to claim your report with captivating visuals.

The ratio of affected babies also fuels the market to come up with more advanced products in the market, for instance, according to WebMD, LLC., 16,000 out of 28,000 born babies are affected by ROP (retinopathy of prematurity) as the babies will be born less than 31 weeks and the weight will be more than 2 pounds in the U.S, The awareness is the hindrance for the product.

New Born Eye Imaging Systems: Overview

Newborn eye imaging systems is a growing market over the forecast period, as many products are coming into the market after getting approval from respective organizations, all the products are in high demand for imaging, for instance, in March 2012, Russia’s third president has approved the purchase of newborn eye imaging system from Clarity Medical Systems, Inc., and launched RetCam digital imaging program in Russian Federation for the treatment of prematurely born infants at risk for eye diseases like ROP (retinopathy of prematurity).

New Born Eye Imaging Systems: Region-wise Outlook

Geographically, the New Born Eye Imaging Systems Market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, the Middle East, and Africa.

North America is the leading market as major players are placed inside and the number of population is effected by new eye problems, for instance, according to the Centers for Disease Control and Prevention in October 2016, one in every 33 babies is affected by eye-borne diseases. Europe is also a potential market as governments are directly involved in the treatment of eye diseases. Asia Pacific is a growing market as the awareness is very low in the market about this system.

New Born Eye Imaging Systems: Key Players

Some players in the New Born Eye Imaging Systems Market include Visunex Medical Systems, Inc., Eye Photo Systems, Merge Healthcare Incorporated, D-EYE S.r.l., Imagine Eyes, Natus Medical Incorporated, and Servicom Medical (Singapore) Pte Ltd.

The report covers an exhaustive analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Get Ahead with Comprehensive Information – Purchase Now!

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, and the Rest of Latin America)
Western Europe (Germany, Italy, France, UK, Spain, Nordic countries, Belgium, Netherlands, Luxembourg, and the Rest of Western Europe)
Eastern Europe (Poland, Russia and Rest of Eastern Europe)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, and Rest of MEA)

New Born Eye Imaging Systems Market: Segmentation

Based on disease type

Retinopathy of prematurity
Ocular development
Refractive state
Strabismus
Visual functions
Visual acuity
Visual fields
Color vision

Based on Device Type

Basic Device
Wireless Device

Based on End User

Hospital
Ophthalmology Diagnosis Centre
Ambulatory Surgical Centre
Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Advanced Infusion System Market Projected to Reach USD 16,536.9 Million by 2033 at a 6.4% of CAGR

The advanced infusion systems market is anticipated to reach USD 16,536.9 million by 2033, from a projected USD 8,862.8 million in 2023. Over the course of the forecast period, advanced infusion system sales are anticipated to grow at a noteworthy CAGR of 6.4%.

The use of sophisticated infusion systems has expanded since they are frequently employed to inject medications and fluids into patients’ bodies for therapeutic purposes. The most common ways that fluids are administered with the aid of an infusion system are intravenous, subcutaneous, and epidural or enteral.

Examine an Enlightening : Report

Precise Dosing and Enhanced Patient Safety: Advanced Infusion Systems Take Center Stage

The global advanced infusion systems market is experiencing significant growth, driven by the growing demand for accurate and controlled medication delivery. These advanced systems offer significant advantages over traditional methods, promoting wider adoption within the healthcare field.

Tailored Treatments for Diverse Needs

Advanced infusion systems allow for the administration of fluids and medications through various routes, including:

Subcutaneous: Delivery of medication just beneath the skin.
Epidural: Delivery of medication into the epidural space, near the spinal cord.
Enteral: Delivery of nutrition directly into the stomach or small intestine.
Intravenous: Delivery of medication directly into the bloodstream.

Key Takeaways:

The global advanced infusion systems market is projected to reach US$16,536.9 million by 2033, reflecting a significant rise from US$8,862.8 million in 2023.
This growth is anticipated at a healthy compound annual growth rate (CAGR) of 6.4% throughout the forecast period.
The increasing adoption of advanced infusion systems for precise and controlled drug delivery is a key driver for market expansion.

Competitive Landscape:

Important Market Players Making Various Efforts to Gain an Advantage

The major players in the market for advanced infusion systems are always working together and putting out great effort to develop high-end infusion systems that will help patients by providing them with more sophisticated and equipped solutions.

Recent Developments

In January 2020, Medtronic (Ireland) Launched Efficio, a cloud-based data management software, for use with the SynchroMed II intrathecal drug delivery system. This enables clinicians to efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer, and severe spasticity.

In March 2020, Q Core Medical Company opened a new manufacturing unit in Europe to capitalize on the opportunities offered by the advanced infusion systems market due to the increasing geriatric population and increasing demand for the adoption of infusion systems in healthcare, therapeutic effectiveness, and reliability.

Key Companies Profiled:

TERUMO CORPORATION
AIS HealthCare
B. Braun Medical Ltd
Medtronic
Baxter
MOOG INC.
armed ag
AVA Biomedical
BD
Smiths Group plc.

In-Depth Market Overview – Now to Access

Advanced Infusion System Market:

By Product:

Elastomeric Infusion System
Volumetric Infusion System- Large Volume and Small Volume Pump
Patient Controlled Analgesia pump
Disposable Infusion System
Syringe Infusion System
Ambulatory Infusion System
Implantable Infusion System

By Application:

Chemotherapy
Diabetes
Pain management
Asthma
Clinical Nutrition

By End User:

Hospitals
Ambulatory Surgical Centers
Diagnostic centers
Bedside

By Region:

North America
Latin America
Europe
South Asia & Pacific
East Asia
The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Myelodysplastic Syndrome Treatment Market is projected to grow at a CAGR of 5.9% and reach USD 5,614.1 Million by 2032 | FMI Study

The global Myelodysplastic Syndrome Treatment Market is poised for significant growth, with a projected revenue of USD 5,614.1 million by 2032. This represents a steady Compound Annual Growth Rate (CAGR) of 5.9% from its current valuation of USD 2,990.8 million in 2022.

Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow are damaged. This damage leads to low numbers of one or more types of blood cells. MDS is considered as a type of cancer.

Myelodysplastic syndromes are a rare group of disorders in which the body no longer makes enough healthy blood cells. This disorder can also be called “bone marrow failure disorder.”

Claim your complimentary report with captivating visuals.

The patient pool is more of an age group of 50 or older, but it can happen to younger people, too. This syndrome is more common in men as compared to women.

According to the American Society of Clinical Oncology (ASCO), approximately 13,000 people in the U.S. are diagnosed with MDS each year.

Myelodysplastic Syndrome Treatment Market: Drivers and Restraints

The Myelodysplastic Syndrome Treatment market is expected to mark a significant growth in the coming few years due to increasing mutation in treatments which cause myelodysplastic syndrome. In addition to this, the growing number of patient pool of age 50 and above, and rising government support for cancer treatment tend to propel the market.

However, unawareness about such treatments is one of the major factors that is delaying the growth of this market.

Myelodysplastic Syndrome Treatment Market: Overview

The global market for myelodysplastic syndrome treatment is expected to witness high growth over the forecast period due to increasing incidences of myelodysplastic syndrome. In the U.S., myelodysplastic syndromes (MDS) occur at a rate of 4.8 cases for every 100,000 people. That works out to about 13,000 new cases of MDS each year. The number of new cases diagnosed each year seems to be increasing as the average age of the population increases. (Source: American Cancer Society).

Furthermore, diagnosis techniques such as blood count, peripheral blood smear test, microscopic exams, cytochemistry, flow cytometry and immunotherapy, cytogenetics, FISH, and PCR help in the detection of MDS, also a key factor that is propelling the myelodysplastic syndrome treatment market towards growth.

Myelodysplastic Syndrome Treatment Market: Regional Outlook

Geographically, the global myelodysplastic syndrome treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America and Europe together dominate the global myelodysplastic syndrome treatment market due to the presence of a large population suffering from bone marrow disease, a rise in healthcare expenditure, and increasing demand for myelodysplastic syndrome treatment by the end users. Asia Pacific’s myelodysplastic syndrome treatment market is expected to be one of the fastest growing markets due to the increasing number of patients with blood marrow disorders.

Myelodysplastic Syndrome Treatment Market: Key Players

The market for myelodysplastic syndrome treatment is consolidated with the presence of a few strong players. Some of the players identified in the global myelodysplastic syndrome treatment market include Celgene Corporation, Otsuka Holdings Co., Ltd., Sandoz, Inc., Dr. Reddy’s Laboratories, Inc., Accord Healthcare Ltd., Mylan N.V., Pfizer, Inc., etc.

The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers an exhaustive analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain

Gain the Edge with Segmented Information – Buy Now!

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
The Middle East and Africa (GCC, South Africa, Rest of MEA)

Myelodysplastic Syndrome Treatment Market: Segmentation

Based on Type

Refractory cytopenia with unilinear dysplasia (RCUD)
Refractory anemia with ringed sideroblasts (RARS)
Refractory cytopenia with multilineage dysplasia (RCMD)
Refractory anemia with excess blasts-1 (RAEB-1)
Refractory anemia with excess blasts-2 (RAEB-2)
Myelodysplastic syndrome, unclassified (MDS-U)
Myelodysplastic syndrome associated with isolated del(5q)

Based on treatment

Chemotherapy
Immunotherapy
Stem cell transplantation/bone marrow transplantation
Growth Factors

Based on the patient group

Above 50 years
Below 50 years

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Transcranial Doppler Ultrasounds System Market Expected to Reach USD 646.1 Million by 2033 at a 7.4% of CAGR

The global transcranial Doppler ultrasound system market is poised for significant growth, with projections indicating a rise from USD 316.8 million in 2023 to approximately USD 646.1 million by 2033. This expansion reflects a robust compound annual growth rate (CAGR) of 7.4% over the forecast period.

Transcranial Doppler ultrasounds are advanced neuroimaging tools used to assess blood flow and detect abnormalities in the brain’s blood vessels. The market’s growth is driven by technological advancements in imaging systems, increasing prevalence of neurological disorders, and rising demand for non-invasive diagnostic solutions.

Examine an Enlightening – Report

TCDs: A Non-Invasive Window into Brain Health

The global transcranial doppler ultrasound (TCD) systems market is experiencing significant growth, driven by the increasing need for effective and non-invasive methods for diagnosing neurological conditions. TCD systems utilize ultrasound waves to measure blood flow velocity within the brain’s basal intracranial arteries.

Broad Spectrum of Applications Fuels Market Growth

The versatility of TCD systems in diagnosing various neurological conditions is propelling market expansion. Key applications include:

Vascular Disorders: TCDs aid in diagnosing stenosis (narrowing), vasospasm (constriction), and emboli (blockages) caused by subarachnoid hemorrhage (bleeding around the brain).
Neurological Conditions: TCDs play a valuable role in identifying arteriovenous malformations (abnormal connections between arteries and veins), cerebral circulatory arrest (blood flow stoppage), and sickle cell disease complications.
Other Applications: TCDs are used in monitoring blood flow during surgery, detecting meningeal infections (inflamed meninges), and evaluating ischemic cerebrovascular disorders (reduced blood flow to the brain).

Key Takeaways:

The global transcranial doppler ultrasound (TCD) systems market is projected to reach US$646.1 million by 2033, reflecting a significant rise from US$316.8 million in 2023.
This growth is anticipated at a strong compound annual growth rate (CAGR) of 7.4% throughout the forecast period.
The rising demand for non-invasive diagnostic tools for neurological conditions is a key driver for market expansion.

Competition Landscape in the Transcranial Doppler Ultrasounds System Market:

According to FMI’s market assessment on transcranial doppler ultrasound systems, there is moderate competition in this industry, which attracts both domestic and overseas enterprises.

In order to strengthen their positions in the market, the industry participants engage in a variety of organic and inorganic tactics, such as alliances, product launches, mergers and acquisitions.

Recent Developments Observed by FMI:

A medical technology and data business called NovaSignal Corp. that specializes in the evaluation and management of brain health announced in March 2022 that Health Canada has approved their NovaGuideTM Intelligent Ultrasound for a Medical Device Licence. Healthcare professionals in Canada may now utilize NovaGuide to record and track the brain’s blood flow in real time.
In order to aid in real-time diagnosis, NovaSignal Inc., headquartered in Los Angeles, introduced a second iteration of their robotic platform in October 2021 that is directed by artificial intelligence (AI). The technology employs ultrasound to automatically record blood flow data, which is subsequently transferred to a cloud system that complies with HIPAA rules so that physicians may view the exam data on any personal device, wherever they are.

Key Players in the Global Market:

ELCAT
Rimed
Natus Medical Incorporated
SMT Medical GmbH & Co. KG
Neural Analytics
Recorders & Medicare Systems Pvt. Ltd.
DX-Systems
Elica
Multigon Industries Inc.
Atys Medica

Transcranial Doppler Ultrasounds System Market Segmentation:

By Product Type:

Wearable
Non-wearable

By Component Type:

Systems
Accessories

By Modality Type:

Standalone
Portable

By End-user:

Hospital
Imaging Diagnostic Centers
Ambulatory Surgical Centers
Others

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)

In-Depth Market Analysis – Purchase Now to Access

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Hybrid Grafts Market Suggested a 5.20% Compound Annual Growth Rate to Reach USD 858.7 Million by 2032 | FMI Report

The global Hybrid Grafts Market is experiencing rapid expansion, fueled by the escalating prevalence of cardiovascular disease. According to recent market analysis, the market is currently valued at USD 517.3 million in 2022 and is projected to reach a substantial USD 858.7 million by 2032, with a Compound Annual Growth Rate (CAGR) of 5.20%. This significant surge highlights the increasing demand for innovative solutions in cardiovascular surgery.

Infections caused by viruses can infect the inner surfaces of veins and arteries, resulting in blood clots, mild blood vessel damage, and inflammation of adjacent blood vessels. These factors can potentially reduce blood flow to the heart and other organs, leading to an increase in cases of cardiovascular disease during the next decade. The number of cases of chronic ascending aortic dissection has also increased considerably globally, adding to market expansion.

Claim your complimentary report with captivating visuals.

Furthermore, prominent market participants are concentrating on developing novel products with increased efficacy, such as environmental stability, infection resistance, and durability. BD Interventional, for example, just launched Distaflo, which combines ePTFE with carbon soaked into the interior parts of the graft wall, as well as a patented cuff at the distal end.

Key Takeaways: Hybrid Grafts Market

The thoracic aortic graft segment represented roughly 78.2% of the market share in 2021 and is expected to dominate the global Hybrid Grafts market by 2032.
The hospital sector is estimated to lead the worldwide Hybrid Grafts market with a 5.9% CAGR during the forecast period.
The North American hybrid Grafts market is expected to generate 42.1% in 2021 and will continue to lead in the coming years.
With the expansion of the healthcare business, China is expected to hold a market share of almost 3.8% in 2032.
Germany’s Hybrid Grafts market held a 3.5% share in 2021 and is expected to remain at the forefront during the evaluation period.

“Rising use of minimally invasive devices in medical procedures is set to drive the Hybrid Grafts market. Besides, increasing number of cardiac and vascular surgeries is anticipated to push demand for Hybrid Grafts to reduce surgical site complications,” says a FMI analyst.

Hybrid Grafts Market Competition

The market for Hybrid Grafts is moderately fragmented and there exists a large number of local, emerging, as well as established players across the globe. Key players are initiating promotional activities to introduce new designs to attract more customers. A few other companies are engaging in collaborations and expansion activities to develop innovative products.

In October 2021, Terumo collaborated with Cell Technologies to construct a new production facility in Costa Rica, which will support the company’s global supply chain.
In May 2022, Getinge invested 3 million Euros to increase its capacity for producing polyester grafts and patches for the treatment of aneurysmal and occlusive illnesses. The investment would enable the company to increase manufacturing capacity at its La Ciotat, France, plant.

Key Players

Terumo Corporation
BD Interventional
Getinge AB
Merit Medical Systems, Inc.
JOTEC GmbH

Contact Sales for Further Assistance in Purchasing this Report!

More Valuable Insights on Hybrid Grafts Market

Future Market Insights offers a unique perspective and actionable insights on the Hybrid Grafts market in its latest study, presenting a historical demand assessment of 2017 to 2021 and projections for 2022 to 2032.

The research study is based on the product (thoracic aortic graft and peripheral vascular graft) and end-user (hospitals and ambulatory surgical centers), across seven key regions of the world.

Hybrid Grafts Market Outlook by Category

By Product:

Thoracic Aortic Graft
Peripheral Vascular Graft

By End User:

Hospitals
Ambulatory Surgical Centers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Motorized Prosthesis Market is Anticipated to Grow at a 14.4% CAGR to Reach USD 139.4 Million by 2032 | FMI Study

The future of mobility is here, and it’s powered by innovation. The Motorized Prosthesis Market is experiencing rapid growth, transforming the lives of amputees worldwide. According to a recent analysis, this market is set to reach a significant USD 139.4 million by 2032, expanding at a robust Compound Annual Growth Rate (CAGR) of 14.4% from its current valuation of USD 31.9 million in 2022.

The motorized prosthesis is an artificial medical device used to perform the functions of missing body parts due to factors such as trauma, congenital factors, or various other diseases. The concept of motorized prosthesis arises from biomedical engineering and neuroscience.

The motorized prosthesis is based on brain brain-computed interface, to avail the biological functioning of missing body parts. The motorized prosthesis is a complex network of motors and cognitive modalities. These devices are made for supporting of autonomous nervous system functioning such as devices for bladder control.

Claim your complimentary report with captivating visuals.

The motorized prostheses are in the research and development phase, and various technological advancements have been witnessed in developing a novelty product to support the body’s normal functioning. The motorized prostheses are based on target muscle innervation (TMR) technology.

Motorized Prosthesis Market: Overview

The motorized prosthesis market is an emerging technology and is adopted by a large number of affected patient population base. The motorized prosthesis is based on the integration with the nervous system to conduct the functioning of the replaced body part by a device known as a controller that maintains the compatibility between the patient’s nervous system and muscular systems.

Motorized prosthesis work by sending users’ commands to the device’s actuators, and deduces the feedback from the biosensors. Motorized hand prostheses are widely used as compared with motorized leg prostheses. Information technology also plays a crucial role in the development of motorized prostheses.

Various programs have been conducted such as open-source robotic prostheses through which various collaborations are made by players for bringing advancement in the technology coupled with lowering the cost of the devices by using 3D printing technology for custom-made fabrication.

Motorized Prosthesis Market: Region Wise Outlook

Geographically, the motorized prosthesis market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is projected to hold the largest share of motorized prostheses in the global market, followed by Western Europe, owing to more developed healthcare infrastructure and ease of access to advanced technology.

In addition, high disposable income, support from governmental bodies, and favorable reimbursement scenarios are driving the growth of the motorized prosthesis market. The market in Asia-Pacific is expected to show the fastest growth over the forecast period owing to the consistent technological advancement, and increasing R&D investment by the public and private bodies.

The market in regions such as Latin America, the Middle East, and Africa is anticipated to show sluggish growth owing to low per capita income, lack of skilled personnel, and limited medical facilities.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, applications, and industries.

Motorized Prosthesis Market: Drivers and Restraints

The motorized prosthesis market is expected to show tremendous growth during the forecast period. Factors such as technological advancement in motorized prostheses, and increasing research and development expenditure to support the lives of affected patients are driving the growth of the motorized prosthesis market.

Increasing healthcare infrastructure along with the growth in IT infrastructure are also driving the growth of the motorized prosthesis market. In addition, according to research studies conducted, approximately 2 million individuals are living without a limb in the U.S. alone, and nearly 185,000 amputations occur in the U.S. every year.

However, the motor prosthesis is in its initial phase of development, and factors such as high developmental cost, and pricing are the major constraints of the motorized prosthesis market growth. The factors such as the modeling of the device, power consumption, size, and biocompatibility are major issues that can hamper the growth of the motorized prosthesis market.

Moreover, due to the presence of batteries and motors, they are likely to be heavy as compared with body-powered prostheses,and thus impede the motorized prosthesis market growth.

Access Exclusive Market Insights – Purchase Now!

Motorized Prosthesis Market: Key Players

Some of the market participants in the global motorized prosthesis market are Advanced Arm Dynamics, Bionic Prosthetics and Orthotics, BionX Medical Technologies, Inc., Faulhaber Group, Freedom Innovations, LLC, Mobius Bionics LLC, Össur hf., Otto Bock HealthCare GmbH, Sensars Neuroprosthetics, and Touch Bionics Inc.

Key Segments :

By Target Population:

Pediatric
Adult

By End-User:

Optics and Hospitals
Orthopedic Clinics
Trauma Centers

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia-Pacific
Japan
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Kaempferol Market Expected to Reach USD 5.86 Billion by 2033 at a 3.8% of CAGR

The global kaempferol market is set for steady growth, with a projected increase from USD 4.33 billion in 2023 to USD 5.86 billion by 2033. This expansion reflects a compound annual growth rate (CAGR) of 3.8% over the forecast period.

Kaempferol, a natural flavonoid known for its various health benefits, is gaining prominence across a range of industries, including dietary supplements, functional foods, and cosmetics. The market’s growth is driven by the rising consumer awareness of health and wellness, as well as the increasing incorporation of kaempferol into various health-oriented products.

Examine an Enlightening : Report

Owing to the increase in urbanization and sedentary lifestyle, people hardly get time to properly maintain their health. So, they start consuming dietary supplements for various factors like obesity management.

Combating Chronic Disease: Kaempferol Emerges as a Natural Ally

The global kaempferol market is experiencing steady growth, driven by the increasing burden of chronic diseases and the growing popularity of natural health supplements. Kaempferol, a naturally occurring flavonoid found in various fruits and vegetables, offers a range of potential health benefits:

Chronic Disease Risk Reduction: Kaempferol may help reduce the risk of chronic diseases like cancer, offering a natural approach to preventative health.
Antioxidant Power: Kaempferol’s antioxidant properties help combat free radicals, protecting cells from damage and potentially reducing the risk of chronic conditions.
Anti-Inflammatory Properties: Kaempferol’s ability to modulate inflammation may provide benefits for various inflammatory conditions.
Cellular Regulation: Kaempferol may play a role in regulating apoptosis, or programmed cell death, which is crucial for maintaining cellular health.

Market Growth Fueled by Lifestyle Trends

Several factors are contributing to the growth of the kaempferol market:

Lifestyle-Related Diseases: The increasing prevalence of chronic diseases associated with modern lifestyles, such as obesity and diabetes, fuels demand for natural health solutions like kaempferol.
Dietary Supplement Boom: The growing awareness of the importance of proactive health management is leading more consumers to turn to dietary supplements. This trend positively impacts the kaempferol market.
Urbanization and Time Constraints: Busy lifestyles in urban environments often leave people with limited time for optimal nutrition. Dietary supplements like kaempferol offer a convenient way to bridge potential nutritional gaps.

Key Takeaways:

The global kaempferol market is expected to reach a value of US$5.86 billion by 2033, reflecting a rise from US$4.33 billion in 2023.
This growth is projected at a consistent compound annual growth rate (CAGR) of 3.8% throughout the forecast period.
The rising prevalence of chronic diseases and growing consumer interest in natural health solutions are key drivers for market expansion.

Competitive Landscape in the Kaempferol Market:

The key players in the kaempferol market are involved in developing more sustainable kaempferol than chemically or botanically derived kaempferol. Moreover, the manufacturers are trying to ensure that the kaempferols obtained through the procedure are available at affordable rates.

In April 2022, Fujifilm Wako Chemicals USA corporation launched Pathoprep 568 for pathological tissue embedding, Anti Iba1, Rabbit, SPICA Dye™ 594-conjugated for immunochemistry and 1H,1H,2H,2H-Perfluorodecyltriethoxysilane for organic synthesis.
In June 2022, Spectrum Chemical entered into a new distribution arrangement with ANGUS chemical company to provide select TRIFF buffers and derivatives for the life sciences and biopharmaceuticals market in the USA and Canada.

Key Players in the Kaempferols Market

Aktin Chemicals Inc.
FUJIFILM Wako Chemicals USA Corporation
Shaanxi NHK Technology
Risun Bio-Tech
TCI Chemicals (India) Pvt. Ltd.
Spectrum Chemical Mfg. Corp.
INDOFINE Chemical Company, Inc.

Key Segments in the Kaempferol Market:

By Purity:

By Application:

Food & Beverages
Cosmetics
Pharmaceuticals
Dietary Supplements

By Region:

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Discover Extensive Market Insights – Purchase Now to Access

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Implantable Collamer Lens Market is predicted to grow at an astonishing 13.1% annual rate and reach USD 1,141.80 Million by 2034 | FMI

The demand for Implantable Collamer Lens Market procedures is skyrocketing, driven by the increasing popularity of minimally invasive eye surgeries. The global ICL market, currently valued at USD 330.5 million in 2024, is projected to reach a staggering USD 1,141.80 million by 2034. This represents an impressive Compound Annual Growth Rate (CAGR) of 13.2% between 2024 and 2034.

Refractive surgeons have favored phakic intraocular implants for the past two decades to address cases of myopia unresponsive to excimer laser treatments. One notable innovation in this field is the Visian Implantable Collamer Lens (ICL), a posterior chamber phakic intraocular lens designed and manufactured by STAAR Surgical. This groundbreaking lens received FDA approval in 2005 and has consistently demonstrated its effectiveness in correcting myopia, with the capacity to address refractive errors of up to 18.00 diopters.

Request a report sample to gain comprehensive insights

The ICL was only offered in the U.S. in a spherical variant until 2018. As a result, high astigmatism and high myopia could not be treated simultaneously. In light of this, several surgeons in the refractive field adopted a sequential operation strategy that employs the use of an excimer-laser enhancement after ICL implantation. This sequence has been referred to as “Bioptics”.

The use of ICL in refractive surgery is increasing. ICLs are often regarded as an alternative to laser-based corneal procedures such as LASIK and photorefractive keratectomy (PRK). The implantable collamer lens is a specific type of posterior chamber phakic intraocular lens (pIOL). High levels of refractive error or situations where corneal refractive surgery is not recommended call for the adoption of pIOL. Quicker healing and reversibility are the additional benefits of this procedure over corneal refractive surgery.

The high incidence of cataracts and other vision impairments among elderly and diabetic individuals is underpinning the need for implantable collamer lenses. In addition to this, rising healthcare costs, and government-backed investments for the construction of healthcare infrastructure are some of the key factors propelling the market.

Key Takeaways from the Implantable Collamer Lens Market:

By indication, sales in the myopia segment are slated to increase at a 12.6% CAGR through 2032.
In terms of end-users, demand in the hospital segment will grow at a 7% CAGR during the forecast period.
China accounted for 6%of the total market share in 2021 and the trend is expected to continue over the assessment period.
The U.S. will continue dominating the North American implantable collamer lens market through 2032.
Japan will emerge as a lucrative pocket in the East Asia implantable collamer lens market.

Competition Landscape from the Implantable Collamer Lens Market

The Global Implantable Collamer Lens Industry includes only one manufacturer known as STAR SURGICAL. Incorporated in 1982 to develop, produce, and market implantable lenses, the company is the first to receive the U.S. FDA approval for implantable collamer lenses. Some recent developments include:

In April 2021, STAAR submitted clinical data to the FDA to support marketing approval for their EVO family of myopia lenses. The submission remains under interactive review with the FDA.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Global Implantable Collamer Lens Industry in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the indication (myopia, hyperopia, and astigmatism), and end-user (hospitals, ophthalmic clinics, ambulatory surgical centers, and eye research institutes), across seven key regions.

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you to devise innovation-driven trajectories for your business.

Access Exclusive Market Insights – Purchase Now!

Key Market Segments Covered in Implantable Collamer Lens Market Research

By Indication:

Myopia
Hyperopia
Astigmatism

By End User:

Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
Eye Research Institutes

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube